A critical advance in cancer investigation is arising with the use of VHH fragments to reactivate mutated p53. This essential tumor suppressor protein is frequently inactivated in several types of tumors, causing https://whitebookmarks.com/story22032773/nanobodies-reactivate-the-p53-protein-the-potential-pathway-for-malignant-treatment